C. Soria

发表

Fibrinogen Bastia (γ 318 Asp → Tyr) a Novel Abnormal Fibrinogen Characterized by Defective Fibrin Polymerization

K. Lounes, J. Koopman, C. Soria, 1999, Thrombosis and Haemostasis.

Hemostasis in Patients Undergoing Extracorporeal Circulation: The Effect of Aprotinin (Trasylol)

J. Soria, C. Soria, He Lu, 1991, Thrombosis and Haemostasis.

Abnormal Fibrin Clot Architecture in Nephrotic Patients Is Related to Hypofibrinolysis: Influence of Plasma Biochemical Modifications

J. Soria, C. Soria, J. Collet, 1999, Thrombosis and Haemostasis.

Cerivastatin, an Inhibitor of HMG-CoA Reductase, Inhibits Urokinase/Urokinase-receptor Expression and MMP-9 Secretion by Peripheral Blood Monocytes

Z Mishal, J. Beaudeux, J Soria, 2000, Thrombosis and Haemostasis.

Postoperative Hemostasis and Fibrinolysis in Patients Undergoing Cardiopulmonary Bypass with or without Aprotinin Therapy

J. Soria, C. Soria, He Lu, 1994, Thrombosis and Haemostasis.

Role of Active Center and Lysine Binding Sites of Plasmin in Plasmin-Induced Platelet Activation and Disaggregation

Hong Li, J. Soria, C. Soria, 1991, Thrombosis and Haemostasis.

Increased Expression of u-PA and u-PAR on Monocytes by LDL and Lp(a) Lipoproteins – Consequences for Plasmin Generation and Monocyte Adhesion

J. Soria, C. Soria, J. Collet, 1999, Thrombosis and Haemostasis.

The plasminogen‐activation system in ovarian tumors

J. Soria, C. Soria, He Lu, 1993, International journal of cancer.

Malignant hematopoietic cells induce an increased expression of VEGFR-1 and VEGFR-3 on bone marrow endothelial cells via AKT and mTOR signalling pathways.

J. Soria, C. Soria, A. Faussat, 2006, Biochemical and biophysical research communications.

SDF-1 activity on microvascular endothelial cells: consequences on angiogenesis in in vitro and in vivo models.

J. Soria, C. Soria, Hong Li, 2000, Thrombosis research.

Plasma factor VII, triglyceride concentration and fibrin degradation products in primary hyperlipidemia: a clinical and laboratory study.

C. Soria, P. Giral, E. Bruckert, 1989, Haemostasis.

Anti-RhoA and anti-RhoC siRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivo.

P. Opolon, Hong Li, J. Soria, 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

Cerivastatin, an inhibitor of HMG-CoA reductase, inhibits the signaling pathways involved in the invasiveness and metastatic properties of highly invasive breast cancer cell lines: an in vitro study.

J. Soria, C. Soria, M. Körner, 2001, Carcinogenesis.

Decrease of breast cancer cell invasiveness by sodium phenylacetate (NaPa) is associated with an increased expression of adhesive molecules

C. Soria, M. Crépin, M. Vasse, 2001, British Journal of Cancer.

Recombinant hirudin: a specific thrombin inhibiting anticoagulant for hemodialysis.

J. Soria, C. Soria, R. Vanholder, 1994, Kidney international.

New insights into the actions of bisphosphonate zoledronic acid in breast cancer cells by dual RhoA-dependent and -independent effects

J. Soria, C. Soria, J. Vannier, 2003, British Journal of Cancer.

Fibronectin increases the migration induced by stromal cell-derived factor-1 alpha (SDF-1 alpha) in pre-B acute lymphoblastic leukemia cells.

P. Schneider, J. Vannier, M. Vasse, 2001, European cytokine network.

Down-regulation of vascular endothelial growth factor by tissue inhibitor of metalloproteinase-2: effect on in vivo mammary tumor growth and angiogenesis.

L. Devy, J. Foidart, A. Noël, 2001, Cancer research.

Carboxymethyl benzylamide dextran blocks angiogenesis of MDA-MB435 breast carcinoma xenografted in fat pad and its lung metastases in nude mice.

C. Soria, He Lu, M. Crépin, 1999, Cancer research.

Severe arterial thrombosis in a congenitally factor VII deficient patient

C. Soria, G. Tobelem, J. Zini, 1995, British journal of haematology.

Embolized ischemic lesions of toes in an afibrinogenemic patient: possible relevance to in vivo circulating thrombin.

C. Soria, P. Bruneval, C. Laurian, 2001, Thrombosis research.

A Pilot Study of Subcutaneous Recombinant Hirudin (HBW 023) in the Treatment of Deep Vein Thrombosis

J. Soria, C. Soria, F. Schiele, 1994, Thrombosis and Haemostasis.

The growth of highly proliferative acute lymphoblastic leukemia may be independent of stroma and/or angiogenesis

C. Soria, P. Schneider, J. Vannier, 2001, Leukemia.

Adenovirus-mediated delivery of a uPA/uPAR antagonist suppresses angiogenesis-dependent tumor growth and dissemination in mice

P. Opolon, J. Soria, C. Soria, 1998, Gene Therapy.

Dysfibrinogenemia (Fibrinogen Dusard) Associated with Impaired Fibrin-Enhanced Plasminogen Activation

J. Soria, C. Soria, D. Collen, 1984, Thrombosis and Haemostasis.

Angiostatin gene transfer: inhibition of tumor growth in vivo by blockage of endothelial cell proliferation associated with a mitosis arrest.

P. Opolon, Hong Li, J. Soria, 1998, Proceedings of the National Academy of Sciences of the United States of America.

Dynamic coronary fibrinolysis evaluation in patients with myocardial infarction and unstable angina by specific plasma fibrin degradation product determination.

J. Soria, C. Soria, C. Boucheix, 1987, Thrombosis research.

Disaggregation of In Vitro Preformed Platelet-Rich Clots by Abciximab Increases Fibrin Exposure and Promotes Fibrinolysis

J. Soria, C. Soria, G. Montalescot, 2001, Arteriosclerosis, thrombosis, and vascular biology.

Possible involvement of two proteins (phosphoprotein and CD9(p24)) in regulation of platelet calcium fluxes

C. Soria, C. Boucheix, R. Bredoux, 1985, FEBS letters.

Plasmin-lnduced Platelet Activation and Disaggregation

Hong Li, He Lu, J. Perrot, 2018 .

A latex immunoassay of fibrin/fibrinogen degradation products in plasma using a monoclonal antibody.

J. Soria, C. Soria, J. Perrot, 1986, Thrombosis research.